Alder Biopharmaceuticals Inc (ALDR) Stock Price, Quote, News and Overview
NASDAQ:ALDR - Nasdaq -
ALDR Quote, Performance and Key Statistics
18.88
-0.04 (-0.21%)
The current stock price of ALDR is 18.88 null. In the past month the price increased by 1.34%. In the past year, price increased by 43.36%.
About ALDR
Company Profile
Alder Biopharmaceuticals Inc. is a clinical-stage biopharmaceutical company. It discovers, develops and seeks to commercialize therapeutic antibodies. It is developing monoclonal antibodies comprising ALD403, for the prevention of migraine; and Clazakizumab, in the treatment of rheumatoid arthritis and psoriatic arthritis. Alder Biopharmaceuticals Inc. is headquartered in Bothell, Washington.
Company Info
Alder Biopharmaceuticals Inc
11804 NORTH CREEK PARKWAY SOUTH
BOTHELL WA 98011
CEO: Robert W. Azelby
Phone: 425-205-2900
Alder Biopharmaceuticals Inc / ALDR FAQ
What is the stock price of Alder Biopharmaceuticals Inc today?
The current stock price of ALDR is 18.88 null. The price decreased by -0.21% in the last trading session.
What is the ticker symbol for Alder Biopharmaceuticals Inc stock?
The exchange symbol of Alder Biopharmaceuticals Inc is ALDR and it is listed on the Nasdaq exchange.
On which exchange is ALDR stock listed?
ALDR stock is listed on the Nasdaq exchange.
What is Alder Biopharmaceuticals Inc worth?
Alder Biopharmaceuticals Inc (ALDR) has a market capitalization of 1.58B null. This makes ALDR a Small Cap stock.
What are the support and resistance levels for Alder Biopharmaceuticals Inc (ALDR) stock?
Alder Biopharmaceuticals Inc (ALDR) has a support level at 18.87 and a resistance level at 18.89. Check the full technical report for a detailed analysis of ALDR support and resistance levels.
Should I buy Alder Biopharmaceuticals Inc (ALDR) stock?
There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:
- The Technical Analysis (TA) tab contains a technical analysis of ALDR, looking at technical quality and support and resistance levels
- The Fundamental Analysis (FA) tab contains a fundamental analysis of ALDR, evaluating the profitability, health, valuation and growth aspects
- Alder Biopharmaceuticals Inc (ALDR) Price Target Forecast and Analysts Ratings to understand what professional analysts say.
- Alder Biopharmaceuticals Inc (ALDR) Sales and EPS estimates to see what analysts future expectations are.
- Alder Biopharmaceuticals Inc (ALDR) Income, Balance Sheet and Cash Flow statements to dive into the historical financials.
- Alder Biopharmaceuticals Inc (ALDR) Insider and Institutional Ownership to learn about the owners and their transactions.
- Alder Biopharmaceuticals Inc (ALDR) Stock Chart to make your own analysis
- Alder Biopharmaceuticals Inc (ALDR) Latest news and press-releases to stay up to date.
Does Alder Biopharmaceuticals Inc (ALDR) stock pay dividends?
ALDR does not pay a dividend.
What is the Price/Earnings (PE) ratio of Alder Biopharmaceuticals Inc (ALDR)?
Alder Biopharmaceuticals Inc (ALDR) does not have a PE ratio as the earnings reported over the last twelve months were negative (-4.45).
ALDR Technical Analysis
ChartMill assigns a technical rating of 8 / 10 to ALDR. When comparing the yearly performance of all stocks, ALDR is one of the better performing stocks in the market, outperforming 98.26% of all stocks.
ALDR Fundamental Analysis
ChartMill assigns a fundamental rating of 2 / 10 to ALDR. ALDR has a bad profitability rating. Also its financial health evaluation is rather negative.
ALDR Financial Highlights
Over the last trailing twelve months ALDR reported a non-GAAP Earnings per Share(EPS) of -4.449999999999999. The EPS increased by 0.89% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | -68.61% | ||
| ROE | N/A | ||
| Debt/Equity | 0.89 |
ALDR Ownership and Analysts
ChartMill assigns a Buy % Consensus number of 78% to ALDR. The Buy consensus is the average rating of analysts ratings from 11 analysts.